OpenText, a global market information management solutions company, announced that Pharmascience, a Canadian manufacturer of branded and generic pharma drugs, has deployed OpenText Content Suite to manage its documents.
Pharmascience produces over 2,000 products with sales in over 60 countries worldwide. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products. The company needed an Enterprise Content Management (ECM) solution to manage and secure its document lifecycle and help respond to increasing regulatory demands. It needed document governance tools, including workflow management, version control, and audit trails.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.